Protein Crystallization Facility
Facility Description
Each Handheld PCF Assembly consists of 35 1 ml sample bottles (5 stacks of 7). Each stack is secured to the Handheld Assembly cap which will provide a conductive path through each of the sample bottle. The Container along with the sample bottles provides three levels of containment for the sample solutions. Each Handheld PCF is approximately 8.2 inches by 4.2 inches in diameter (1.9L).
Availability:The general availability status of the facility. Please contact the facility manager
ISS Environment:The facility location (internal or external to the ISS.) Internal
Owner:The entity that owns the facility. UAB-EITD
Operator/Implementation Partner:The entity or ISS National Lab Implementation Partner that operates the facility.
UAB-EITD
Developer(s):The entity, or entities, that developed the facility.
University of Alabama at Birmingham - Engineering and Innovative Technology Development (UAB-EITD)
Facility Manager:The name of the facility manager and their organization.
Chad Duke
University of Alabama at Birmingham
Manager Email:The facility manager's email address.
chadduke@uab.edu
Parent Facility:Any facility that is necessary to operate the facility described on this webpage. i.e., a parent facility is one level higher in the operational hierarachy.
Child Facility:Facilities that can be operated within the facility described on this webpage.
Sponsoring Space Agency:The government space agency that sponsors investigations that use the facility. NASA
Equipment Category:"The facility's ISS National Lab equipment designation type. Designations include:
1. ISS National Lab Commercial Service Provider (CSP) Facility
2. Support Hardware
3. Capability Capability
Additional Information:Additional resources to learn more about the facility.
UAB-EITD Handheld PCF
UAB Engineering and Innovative Technology Development
Pembrolizumab microgravity crystallization experimentation
Protein crystal growth in microgravity review of large scale temperature induction method: Bovine insulin, human insulin and human α-interferon
Pembrolizumab microgravity crystallization experimentation